The Potential of Authorised Drugs to be Repurposed for the Treatment of Osteoarthritis: A Scoping Review of Clinical Studies. [PDF]
DrugsHeijman MWJ +4 more
europepmc +1 more source
Low-Dose Methotrexate Toxicity Presenting With Inguinal Lesions and Pancytopenia: A Case Report. [PDF]
CureusClark KA +3 more
europepmc +1 more source
On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors. [PDF]
Rheumatol TherMease PJ +13 more
europepmc +1 more source
Association of Disease-Modifying Antirheumatic Drugs (DMARDs) with Cardiovascular Diseases: Evidence from a Drug Target Mendelian Randomization Study. [PDF]
Glob HeartZhuo C +5 more
europepmc +1 more source
Prednisone prescribing for rheumatoid arthritis management in primary care: Mixed-methods study of trends and patient perspectives. [PDF]
Can Fam PhysicianPham ANQ +7 more
europepmc +1 more source
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization study. [PDF]
Brain Behav Immun HealthKushnir CN +3 more
europepmc +1 more source
Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification. [PDF]
CirculationArmstrong A, Pugh D, Basu N, Dhaun N.
europepmc +1 more source
Developments and Challenges in Treating Rheumatoid Arthritis-Related Interstitial Lung Disease: From Pathogenesis to Treatment Opportunities. [PDF]
DrugsSebastiani M, Luppi F, Bendstrup E.
europepmc +1 more source
Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases? [PDF]
J Clin MedMısırcı S +6 more
europepmc +1 more source